Title : Intraperitoneal CMP-001: A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer.

Pub. Date : 2021 Feb

PMID : 32409965






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In murine PC models, intraperitoneal CMP-001 treatment elicited an anti-tumor immune response including an increase in chemokines (RANTES and MIP-1beta), pro-inflammatory cytokines (IFNgamma, interleukin 6 [IL-6], and IL-12), and peritoneal/tumor immune infiltration (CD4+/CD8+ T and natural killer [NK] cells). Cytidine Monophosphate interferon gamma Mus musculus